GlycoVaxyn Company
GlycoVaxyn AG, a vaccine biopharmaceutical company, develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections.
Employee Number:
11-50
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Founded Date:
2004-01-01
Industry:
Vaccines & Immunotherapy
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41447338585
Investors:
Edmond de Rothschild Private Equity, Index Ventures, Sofinnova Partners
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland